Hideka Miura

855 total citations
22 papers, 597 citations indexed

About

Hideka Miura is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Hideka Miura has authored 22 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Hideka Miura's work include Influenza Virus Research Studies (13 papers), Respiratory viral infections research (11 papers) and HIV Research and Treatment (5 papers). Hideka Miura is often cited by papers focused on Influenza Virus Research Studies (13 papers), Respiratory viral infections research (11 papers) and HIV Research and Treatment (5 papers). Hideka Miura collaborates with scholars based in Japan, United States and Uganda. Hideka Miura's co-authors include Wataru Sugiura, Shinji Watanabe, Seiichiro Fujisaki, Masakazu Matsuda, Hiroko Morita, Kazuya Nakamura, Emi Takashita, Masayuki Shirakura, Fumihiro Taguchi and Zene Matsuda and has published in prestigious journals such as Journal of Virology, Journal of Clinical Microbiology and Emerging infectious diseases.

In The Last Decade

Hideka Miura

22 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideka Miura Japan	11	294	266	205	121	117	22	597
Lisa A. Lopez United States	9	240 0.8×	331 1.2×	277 1.4×	150 1.2×	140 1.2×	11	671
Claudia Aberham Austria	11	140 0.5×	467 1.8×	400 2.0×	274 2.3×	137 1.2×	15	756
Justin D. Hoopes United States	11	335 1.1×	208 0.8×	32 0.2×	152 1.3×	183 1.6×	11	625
Zhiwu Sun China	10	170 0.6×	222 0.8×	92 0.4×	81 0.7×	61 0.5×	12	377
Sandra L. Bixler United States	15	146 0.5×	318 1.2×	155 0.8×	78 0.6×	220 1.9×	19	589
Julia E. Biggins United States	12	180 0.6×	483 1.8×	62 0.3×	132 1.1×	101 0.9×	17	721
Marcy E. Armstrong United States	8	318 1.1×	155 0.6×	42 0.2×	132 1.1×	91 0.8×	8	468
Arun V. Iyer United States	8	224 0.8×	156 0.6×	46 0.2×	73 0.6×	118 1.0×	11	404
Ona Barauskas United States	9	183 0.6×	244 0.9×	58 0.3×	142 1.2×	36 0.3×	15	513
Kazuhiko Kanou Japan	15	169 0.6×	237 0.9×	22 0.1×	145 1.2×	77 0.7×	34	557

Countries citing papers authored by Hideka Miura

Since Specialization

Citations

This map shows the geographic impact of Hideka Miura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideka Miura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideka Miura more than expected).

Fields of papers citing papers by Hideka Miura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideka Miura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideka Miura. The network helps show where Hideka Miura may publish in the future.

Co-authorship network of co-authors of Hideka Miura

This figure shows the co-authorship network connecting the top 25 collaborators of Hideka Miura. A scholar is included among the top collaborators of Hideka Miura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideka Miura. Hideka Miura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takashita, Emi, Kanju Saka, Hiroko Morita, et al.. (2025). Impact of the polymerase acidic protein E199K substitution in influenza A viruses on baloxavir susceptibility. Antiviral Research. 239. 106173–106173. 1 indexed citations

Takashita, Emi, Hiroko Morita, Seiichiro Fujisaki, et al.. (2025). Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024. Emerging infectious diseases. 31(5). 1019–1023. 1 indexed citations

Takashita, Emi, Masataka Ichikawa, Seiichiro Fujisaki, et al.. (2024). Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients. International Journal of Infectious Diseases. 146. 107134–107134. 1 indexed citations

Shimizu, Kohei, Chiharu Kawakami, Yoko Matsuzaki, et al.. (2024). Monitoring Influenza C and D Viruses in Patients With Respiratory Diseases in Japan, January 2018 to March 2023. Influenza and Other Respiratory Viruses. 18(6). e13345–e13345. 1 indexed citations

Takashita, Emi, Kohei Shimizu, Shuzo Usuku, et al.. (2024). An outbreak of influenza A(H1N1)pdm09 antigenic variants exhibiting cross-resistance to oseltamivir and peramivir in an elementary school in Japan, September 2024. Eurosurveillance. 29(50). 2 indexed citations

Takashita, Emi, Seiichiro Fujisaki, Hiroko Morita, et al.. (2023). Assessment of the frequency of SARS-CoV-2 Omicron variant escape from RNA-dependent RNA polymerase inhibitors and 3C-like protease inhibitors. Antiviral Research. 216. 105671–105671. 5 indexed citations

Takashita, Emi, Seiichiro Fujisaki, Hiroko Morita, et al.. (2023). A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023. Eurosurveillance. 28(39). 9 indexed citations

Sakai, Yusuke, Naoko Iwata‐Yoshikawa, Shinji Watanabe, et al.. (2023). Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters. Journal of Virology. 97(1). e0136622–e0136622. 6 indexed citations

Miura, Hideka, Yoshihiro Ozeki, Tsutomu Omatsu, et al.. (2020). The Single E627K Amino Acid Substitution in PB2 Enhances the Pathogenicity of Wild-Bird-Origin H6N6 Subtype Avian Influenza Virus in Mice. 7(1). 1 indexed citations

10.

Takashita, Emi, Hiroko Morita, Seiichiro Fujisaki, et al.. (2020). Detection of a Peramivir-Resistant Influenza B/Yamagata-Lineage Virus Imported from Indonesia in Aichi, Japan, March 2019. Japanese Journal of Infectious Diseases. 73(5). 386–390. 1 indexed citations

11.

Nakauchi, Mina, Emi Takashita, Seiichiro Fujisaki, et al.. (2020). Rapid detection of an I38T amino acid substitution in influenza polymerase acidic subunit associated with reduced susceptibility to baloxavir marboxil. Influenza and Other Respiratory Viruses. 14(4). 436–443. 12 indexed citations

12.

Takashita, Emi, Chiharu Kawakami, Hiroko Morita, et al.. (2019). Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance. 24(3). 73 indexed citations

13.

Takashita, Emi, Masataka Ichikawa, Hiroko Morita, et al.. (2019). Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019. Emerging infectious diseases. 25(11). 2108–2111. 75 indexed citations

14.

Hirai, Asuka, Toshio Ikeda, Dianna M. Blau, et al.. (2010). Role of Mouse Hepatitis Virus (MHV) Receptor Murine CEACAM1 in the Resistance of Mice to MHV Infection: Studies of Mice with Chimeric mCEACAM1a and mCEACAM1b. Journal of Virology. 84(13). 6654–6666. 20 indexed citations

15.

Miyauchi, Kosuke, Jun Komano, Emiko Urano, et al.. (2006). Rapid Propagation of Low-Fitness Drug-Resistant Mutants of Human Immunodeficiency Virus Type 1 by a Streptococcal Metabolite Sparsomycin. Antiviral chemistry & chemotherapy. 17(4). 167–174. 7 indexed citations

16.

Miura, Hideka, Masakazu Matsuda, Zene Matsuda, et al.. (2006). Use of New T-Cell-Based Cell Lines Expressing Two Luciferase Reporters for Accurately Evaluating Susceptibility to Anti-Human Immunodeficiency Virus Type 1 Drugs. Journal of Clinical Microbiology. 45(2). 477–487. 22 indexed citations

17.

Yan, Hua, Nobuhiko Nomura, Tadakazu Takakura, et al.. (2005). A Novel Small Molecular Weight Compound with a Carbazole Structure That Demonstrates Potent Human Immunodeficiency Virus Type-1 Integrase Inhibitory Activity. Antiviral chemistry & chemotherapy. 16(6). 363–373. 26 indexed citations

18.

Yokomaku, Yoshiyuki, Hideka Miura, Hiroko Tomiyama, et al.. (2004). Impaired Processing and Presentation of Cytotoxic-T-Lymphocyte (CTL) Epitopes Are Major Escape Mechanisms from CTL Immune Pressure in Human Immunodeficiency Virus Type 1 Infection. Journal of Virology. 78(3). 1324–1332. 108 indexed citations

19.

Matsuda, Masakazu, et al.. (2003). Patterns of Point Mutations Associated With Antiretroviral Drug Treatment Failure in CRF01_AE (Subtype E) Infection Differ From Subtype B Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(3). 336–342. 84 indexed citations

20.

Miura, Hideka, Keiko Nakagaki, & Fumihiro Taguchi. (2003). N-Terminal Domain of the Murine Coronavirus Receptor CEACAM1 Is Responsible for Fusogenic Activation and Conformational Changes of the Spike Protein. Journal of Virology. 78(1). 216–223. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact